by Shrader Law | Mar 19, 2013 | Mesothelioma
A new study suggests that mesothelioma patients who have a protein known as CD9 are likely to have a longer life expectancy than patients whose cells do not express this protein. According to researchers at Hiroshima University in Japan, the cell surface protein that aids with cell growth, adhesion, and mobility, is already linked with other types of cancer. A team at the Institute of Biomedical...
View Article